Literature DB >> 9311834

Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours.

S T Andreadis1, D Brott, A O Fuller, B O Palsson.   

Abstract

Replication-incompetent recombinant retroviruses are currently used for gene delivery. The limited efficiency of gene transfer using these vectors hampers implementation of gene therapy. Successful integration of Moloney murine leukemia virus (MMuLV)-derived retroviral vectors into the host cell DNA requires cell division. The time difference between virus entry and cell division is variable and prolonged in slowly dividing cells. Therefore, the rate of intracellular decay of internalized vectors between the time of entry into the target cell and cell division may limit the probability of successful integration following viral entry. We present two methods that measure the intracellular stability of MMuLV-derived retroviral vectors in NIH 3T3 cells. The first is based on a temporary interruption of cell cycle progression by using cell detachment. This method provides an estimate, but not a direct measurement, of the half-life. The results show that the MMuLV intracellular half-life is on the order of but shorter than the total cell cycle time. The second method allows the direct measurement of the intracellular half-life by using two cell cycle-specific labels: 5-bromodeoxyuridine, a thymidine analog that labels cells in S-phase; and the viral vector that labels cells in mitosis. By varying the time between the administration of the two labels, the intracellular half-life is measured to be in the range of 5.5 to 7.5 h. Such a short intracellular half-life may restrict the efficiency of gene transfer by retroviral vectors, particularly in slowly dividing target cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311834      PMCID: PMC192101          DOI: 10.1128/JVI.71.10.7541-7548.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses.

Authors:  E F Fritsch; H M Temin
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

2.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

3.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.

Authors:  O Danos; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment.

Authors:  J P Bader
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

5.  Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells.

Authors:  A Zetterberg; O Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Cell cycle perturbations in normal and transformed fibroblasts caused by detachment from the substratum.

Authors:  J Campisi; E E Medrano
Journal:  J Cell Physiol       Date:  1983-01       Impact factor: 6.384

7.  Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus.

Authors:  J Harel; E Rassart; P Jolicoeur
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

8.  Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.

Authors:  J G Levin; M J Rosenak
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration.

Authors:  T Fujiwara; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  16 in total

1.  Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells.

Authors:  A Lieber; M A Kay; Z Y Li
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Lentiviral vectors in gene therapy: their current status and future potential.

Authors:  David Escors; Karine Breckpot
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-02-09       Impact factor: 4.291

3.  Effect of serum on transfection by polyethylenimine/virus-like particle hybrid gene delivery vectors.

Authors:  David M Drake; Rahul K Keswani; Daniel W Pack
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

4.  Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays.

Authors:  Shruti D Raut; Pedro Lei; Roshan M Padmashali; Stelios T Andreadis
Journal:  J Control Release       Date:  2010-02-11       Impact factor: 9.776

5.  Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway.

Authors:  L J Katen; M M Januszeski; W F Anderson; K J Hasenkrug; L H Evans
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells.

Authors:  V Solodushko; B Fouty
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

7.  Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice.

Authors:  Soon-Kyung Hwang; Hwang-Tae Lim; Arash Minai-Tehrani; Eun-Sun Lee; Jongmin Park; Seung Bum Park; George R Beck; Myung-Haing Cho
Journal:  Am J Respir Crit Care Med       Date:  2009-03-12       Impact factor: 21.405

8.  Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity.

Authors:  Amy H Lin; Cindy Burrascano; Par L Pettersson; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

9.  Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.

Authors:  Yue Si; Anna C Pulliam; Yvonne Linka; Samantha Ciccone; Cordula Leurs; Jin Yuan; Olaf Eckermann; Stefan Fruehauf; Sean Mooney; Helmut Hanenberg; D Wade Clapp
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

10.  Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection.

Authors:  S Andreadis; T Lavery; H E Davis; J M Le Doux; M L Yarmush; J R Morgan
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.